Canada Leukapheresis Market Size & Outlook, 2025-2030
Related Markets
Canada leukapheresis market highlights
- The Canada leukapheresis market generated a revenue of USD 8.7 million in 2024 and is expected to reach USD 17.3 million by 2030.
- The Canada market is expected to grow at a CAGR of 12.4% from 2025 to 2030.
- In terms of segment, leukapheresis devices was the largest revenue generating product in 2024.
- Leukapheresis Disposables is the most lucrative product segment registering the fastest growth during the forecast period.
Leukapheresis market data book summary
| Market revenue in 2024 | USD 8.7 million |
| Market revenue in 2030 | USD 17.3 million |
| Growth rate | 12.4% (CAGR from 2025 to 2030) |
| Largest segment | Leukapheresis devices |
| Fastest growing segment | Leukapheresis Disposables |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Leukapheresis Devices, Leukapheresis Disposables |
| Key market players worldwide | Charles River Laboratories International Inc, Adacyte Therapeutics, AllCells, Haemonetics Corp, Macopharma, Cerus Corp, Kawasumi Laboratories, StemExpress, Lonza Group Ltd, Asahi Kasei Corp |
Other key industry trends
- In terms of revenue, Canada accounted for 4.1% of the global leukapheresis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. leukapheresis market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 17.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Leukapheresis Market Scope
Leukapheresis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| PuriBlood Medical | View profile | 11-50 | Hsinchu, T'ai-wan, Taiwan, Asia | http://www.puriblood.com/index.php |
| Guangzhou Daji Medical Science and Technology Co. | View profile | 51-100 | Guangzhou, Guangdong, China, Asia | https://www.dajimed.com |
| Caltag Medsystems | View profile | 11-50 | Buckingham, Buckinghamshire, United Kingdom, Europe | https://www.caltagmedsystems.co.uk/ |
| Terumo BCT | View profile | 1001-5000 | Lakewood, Colorado, United States, North America | https://www.terumobct.com |
| StemExpress | View profile | 51-100 | Folsom, California, United States, North America | https://www.stemexpress.com/ |
| Kawasumi Laboratories | View profile | 1001-5000 | Minato, Chiba, Japan, Asia | http://www.kawasumi.jp/e/ |
| AllCells | View profile | 51-100 | Alameda, California, United States, North America | https://www.allcells.com |
| Adacyte Therapeutics | View profile | 11-50 | Sant Cugat Del Vallès, Catalonia, Spain, Europe | https://www.adacyte.com |
| Macopharma | View profile | 1001-5000 | Tourcoing, Nord-Pas-de-Calais, France, Europe | https://www.macopharma.com/en/ |
| ZenBio | View profile | 11-50 | Durham, North Carolina, United States, North America | http://www.zen-bio.com/ |
| Haemonetics Corp | View profile | 3657 | 125 Summer Street, Boston, MA, United States, 02110 | https://www.haemonetics.com |
| Cerus Corp | View profile | 280 | 1220 Concord Avenue, Suite 600, Concord, CA, United States, 94520 | https://www.cerus.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | http://www.miltenyibiotec.com |
| Asahi Kasei Corp | View profile | 48897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | http://www.asahi-kasei.co.jp |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
Canada leukapheresis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to leukapheresis market will help companies and investors design strategic landscapes.
Leukapheresis devices was the largest segment with a revenue share of 77.01% in 2024. Horizon Databook has segmented the Canada leukapheresis market based on leukapheresis devices, leukapheresis disposables covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada leukapheresis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada leukapheresis market databook
-
Our clientele includes a mix of leukapheresis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada leukapheresis market , including forecasts for subscribers. This country databook contains high-level insights into Canada leukapheresis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada Leukapheresis Devices - Leukapheresis Market size, 2024 - 2030 (US$M)
Canada Leukapheresis Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
